You are here

  • Home
  • Archive
  • Volume 8, Issue 11
  • Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study

Citation Tools

Article menu

Download PDFPDF

XML
Diagnostics
Research
Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Graziadio S, O’Leary RA, Stocken DD, et al
Can mid-regional pro-adrenomedullin (MR-proADM) increase the prognostic accuracy of NEWS in predicting deterioration in patients admitted to hospital with mild to moderately severe illness? A prospective single-centre observational study
BMJ Open 2018;8:e020337. doi: 10.1136/bmjopen-2017-020337